A 42-year-old woman recently diagnosed with rheumatoid arthritis asks the nurse practitioner about disease-modifying antirheumatic drugs (DMARDs). Which of the following statements about DMARDs is INCORRECT?

DMARDs target the underlying disease

DMARDs limit joint damage and improve function

DMARDs include different classes of medications and are available orally, via subcutaneous injection, or via IV infusion

Patients can begin to experience symptom improvement 3 weeks after DMARD initiation